BetterLife Pharma Inc. (BETR:CSE) closed at $0.200 on November 13, 2026, down 6.98% on the day. The stock trades 56.5% below its 52-week high of $0.460 and 400.0% above its 52-week low of $0.040. Over the past year, it gained 233.3%. BetterLife Pharma Inc. is part of the Life Sciences sector.
In 252 trading sessions since November 13, 2025, BETR closed higher on 75 days (30%). Its best day was June 25, 2026 (+33.33%) and its worst was August 10, 2026 (-28.24%). The stock moved 10% or more in a single session 42 times. It opened at least 5% above the previous day's high 18 times.
BetterLife Pharma Inc is a wellness company engaged in offering self-care products to its customers. It has developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies. The company's technology includes Ready To Infuse Cannabis, Thrudermic, Solmic, and BiPhasix. It has one segment, development and commercialization of patented, differentiated and premium quality nutraceuticals and pharmaceuticals.
Find more stocks like BETR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.